WBA Stock Recent News

Walgreens (WBA) faces a challenging outlook with weak profit forecasts and negative EPS revisions, but technical signals suggest a potential upside, prompting a buy rating. Despite bearish trends and a recent dividend cut, WBA's valuation metrics are extremely low, making it a high-risk, potentially undervalued investment. Key risks include a shift away from physical stores and commercial real estate weakness, but WBA's free cash flow remains positive, mitigating immediate cash-burn concerns.

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA) common stock between July 1, 2021 and June 26, 2024, inclusive (the “Class Period”). Walgreens investors have until November 18, 2024 to file a lead plaintiff motion. Investors suffering losses on their Walgreens investments are encouraged to contact the Law Offices of.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Walgreens investments or would like to inquire about potentially pursuing claims to recover your loss under the federa.

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA) investors concerning the Company's possible violations of federal securities laws. On June 27, 2023, Walgreens released its third quarter fiscal 2023 financial results, falling below analysts' expectations. Additionally, the Company lowered its fiscal 2023 guidance due to “a slower profit ramp for U.S. health care” rel.

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. Walgreens Boots Alliance presently has a stellar rank, in the top 10% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.

High dividend yields can trick investors into buying low-quality or distressed stocks. Walgreens faces several challenges that have deteriorated its fundamentals.

In the most recent trading session, Walgreens Boots Alliance (WBA) closed at $8.53, indicating a -0.35% shift from the previous trading day.

WBA is currently facing challenges within its U.S. Retail Pharmacy segment due to an unfavorable consumer environment and adverse pharmacy industry trends.

Walgreens is struggling and is considering closing stores and selling assets. It brought on a new CEO last year who appears to be considering a wide range of possible moves for the business.

SAN DIEGO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of purchasers of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) (“Walgreens” or the “Company”) common stock between July 1, 2021 and June 26, 2024, inclusive (the “Class Period”), charging the Company and certain of its current and former senior executives with violations of the federal securities laws (collectively, “Defendants”).